Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03AL" (26)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Fenoterol and Ipratropium Bromide (R03AL01) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Berodual N
200 inhalation(s)
12.21
29.70
10 %
Metered dose aerosol: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Salbutamol and Ipratropium Bromide (R03AL02) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Dospir
60 unidose(s)
16.00
33.70
10 %
Lösung für einen Vernebler (Einzeldosen): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Ipramol Steri-Nebs
60 unidose(s)
14.40
32.10
10 %
Inhalation solution: 2 Active Agents
Teva Pharma AG
●
B / SL / SG
FB
G
IP
CI
Dospir
20 unidose(s)
PR
PR
k.A.
Lösung für einen Vernebler (Einzeldosen): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Vilanterol and Umeclidinium Bromide (R03AL03) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Anoro Ellipta 55 mcg/22 mcg
30 unidose(s)
44.48
64.80
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Anoro Ellipta 55 mcg/22 mcg
3 x 30 unidose(s)
133.45
161.55
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Indacaterol and Glycopyrronium Bromide (R03AL04) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Ultibro Breezhaler 110/50
30 Capsule(s)
45.57
66.00
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Ultibro Breezhaler 110/50
90
136.55
164.90
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
Olodaterol and Tiotropium Bromide (R03AL06) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Spiolto Respimat 2.5 mcg / 2.5 mcg
46.84
67.35
10 %
Lösung zur Inhalation (wiederverwendbar): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiolto Respimat 2.5 mcg / 2.5 mcg
3
140.52
169.25
10 %
Lösung zur Inhalation (wiederverwendbar): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (R03AL08) 2 products
WHO-DDD
L
IP
CI
Trelegy Ellipta
30
64.92
87.00
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Trelegy Ellipta
3 x 30
194.75
228.20
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Formoterol, Glycopyrronium Bromide and Beclometasone (R03AL09) 9 products
WHO-DDD
Trimbow 88/5/9
120
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
Trimbow 88/5/9
360
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
L
IP
Trimbow 172/5/9 mcg
62.07
83.90
10 %
Chiesi SA
B / SL
FB
G
L
IP
Trimbow 172/5/9 mcg
360
185.63
218.30
10 %
Chiesi SA
B / SL
FB
G
L
IP
CI
Trimbow 87/5/9 mcg
120
57.99
79.50
10 %
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B / SL
FB
G
L
IP
CI
Trimbow 87/5/9 mcg
360
173.39
205.00
10 %
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B / SL
FB
G
IP
Trimbow 172/5/9 mcg
PR
PR
k.A.
Chiesi SA
B
FB
G
IP
Trimbow 172/5/9 mcg
240
PR
PR
k.A.
Chiesi SA
B
FB
G
IP
CI
Trimbow 87/5/9 mcg
60
PR
PR
k.A.
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B
FB
G
Formoterol, Glycopyrronium Bromide and Budesonide (R03AL11) 2 products
WHO-DDD
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
120
61.59
83.40
10 %
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
360
184.77
217.35
10 %
AstraZeneca AG
B / SL
FB
G
Indacaterol, Glycopyrronium Bromide and Mometasone (R03AL12) 3 products
WHO-DDD
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
90
189.33
222.30
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
k.A.
Novartis Pharma
Schweiz AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
